Key result
Dilated cardiomyopathy was associated with higher immunoreactivity to cardiac ventricular myosin compared to ischemic cardiomyopathy, with of patients testing positive for antibodies against normal ventricular myosin.
Why the study?
Do antibody titers against atrial and ventricular cardiac myosin differ between patients with dilated cardiomyopathy, ischemic cardiomyopathy, and healthy donors?
Case-Control (n=138)
No
Do antibody titers against atrial and ventricular cardiac myosin differ between patients with dilated cardiomyopathy, ischemic cardiomyopathy, and healthy donors?
Answers are grounded in this paper and cite their sources.
High titers of antibodies against ventricular myosin are significantly more prevalent in patients with dilated cardiomyopathy compared to those with ischemic cardiomyopathy, suggesting a specific autoimmune component in DCM.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bobyk et al. (1999) conducted a case-control in Dilated cardiomyopathy (n=138). Dilated cardiomyopathy vs. Ischemic cardiomyopathy was evaluated on Antibody-positivity to normal ventricular myosin (p=0.02). Dilated cardiomyopathy was associated with higher immunoreactivity to cardiac ventricular myosin compared to ischemic cardiomyopathy, with of patients testing positive for antibodies against normal ventricular myosin.
Synapse has enriched 10 related papers. Consider them for comparative context: